You searched for "regulation"
Post-Brexit deal welcomed but leaves future relationship with EU far from settled
6 April 2021
| Rod McNeil
|
EYE - General
Rod McNeil breaks down the impact of the Brexit deal on healthcare in the UK, including medicines regulation, research funding, sharing of information and the ability to work abroad. A disorderly no-deal exit from the European Union (EU) was averted...
Amendments to NHS performers list regulations
1 August 2023
|
NHS, NHS England
The Department of Health and Social Care (DHSC) recently conducted a very short consultation without notice regarding changes to the NHS (England, Performers Lists) Regulation 2013.
“We try our best”, but we should still be open and transparent
1 February 2018
| Vishnu B Madhok
|
EYE - General
In a recent discussion with colleagues, someone recognised that many, when asked what they do, say, “I am a doctor”. Rather than “I work as a doctor”. This sense of belonging, pride and duty comes with responsibility. Becoming a surgeon,...
MicroRNA inhibits corneal neovascularisation
1 August 2018
| Graham Wallace
|
EYE - Cornea, EYE - General
|
Biomechanical stress, Corneal epithelium, MicroRNA-204, Neovascularization, VEGF, VEGFR2
MicroRNAs (miR) are small non-coding RNA that target mRNA for destruction. MiR target about 30% of the protein coding genes and fine tune their expression. MiR have been shown to be involved in several cellular processes including cell cycle, tissue...
EU: is it time to leave and embrace the world?
1 June 2016
| Rod McNeil
|
EYE - General
Should the United Kingdom remain a member of the European Union (EU) or leave? It’s a big decision involving some complex issues, and there’s no doubt the EU will continue to change. Ipsos MORI’s monthly EU voting intention poll published...
Patient safety – is this achieved in optometry with CET?
1 August 2018
| Janet Pooley
|
EYE - General
Collecting points and ticking boxes – as we come to the end of another three year cycle of continuing education and training (CET), the rush to ensure that everything has been completed on the myGOC (General Optical Council) dashboard feels...
Cytokine levels in vitreous fluid in patients with pathological myopia
1 April 2020
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
Pathological myopia (PM) is a leading cause of irreversible visual impairment worldwide, and efforts are dedicated to the study of its underlying mechanisms. Axial extension of the eyeball is regulated via a cascade of biochemical molecules that are initiated in...
GDPR, email and private practice
1 June 2018
| David Haider
|
EYE - General
A new set of data protection regulations became law in the EU (including the UK) in May 2018. General Data Protection Regulation (GDPR) replaces the 1988 Data Protection Act. The regulation brings new rights and expectations about how our personal...
Insights on medical AI for ophthalmology: an update on current perspectives
3 June 2024
| Rod McNeil
|
EYE - General
Artificial intelligence (AI) has immense promise for revolutionising medical practice. Generative AI is a form of AI in which algorithms are trained on datasets that can be used to generate new content, such as text, images or video based on...
MicroRNA mediate retinoblastoma signal transduction
1 October 2014
| Graham Wallace
|
EYE - Vitreo-Retinal
MicroRNAs (miR) are small non-coding single-stranded RNA molecules, normally 22 nucleotides long. There is a large family of miR that control protein expression by binding to mRNAs, leading to their degradation. One important role of miR is in tumours where...
Review of non-arteritic anterior ischaemic optic neuropathy
1 October 2016
| Chrysostomos D Dimitriou
|
EYE - Neuro-ophthalmology
|
Neuroprotection, optic nerve ischemia, optic nerve vasculature, primate models, rodent models
This article reviews the risk factors, clinical presentation and therapies that have been investigated for non-arteritic anterior ischaemic optic neuropathy (NAAION). Additionally, it provides an update from recent rodent and primate models, offering a new insight into the pathophysiology of...
Ovarian hormones drive onset of Sjogren’s disease in mice
1 December 2014
| Graham Wallace
|
EYE - Cornea, EYE - General
|
Sjögren’s Syndrome, lacrimal glands, sex hormones, cytokines, anti-Ro/SSA, anti-La/SSB, NOD.B10.H2b
Sjogren’s syndrome (SS) is a debilitating, sight-threatening, systemic autoimmune disease with no effective treatment available. SS is characterised by lacrimal gland lymphocytic infiltration and epithelial cell death, as well as by the presence of serum autoantibodies. Patients have severe dry...
